말용 동물 치료제 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2032년)

Persistence Market Research has recently released a comprehensive report on the worldwide market for equine veterinary therapeutics. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global equine veterinary therapeutics market from 2025 to 2032.

Key Insights:

• Equine Veterinary Therapeutics Market Size (2025E): USD 1.4 Billion
• Projected Market Value (2032F): USD 2.3 Billion
• Global Market Growth Rate (CAGR 2025 to 2032): 6.7%

Equine Veterinary Therapeutics Market - Report Scope:

Equine veterinary therapeutics are critical for the prevention, diagnosis, and treatment of health conditions affecting horses. The market includes pharmaceuticals, vaccines, and nutritional supplements tailored to address equine-specific needs. These therapeutics are extensively used by veterinarians, equine clinics, and horse owners for the management of infections, joint disorders, parasitic infestations, and other health issues. Market growth is driven by rising awareness of equine health, increasing investments in equestrian sports, and advancements in veterinary medicine. The market also benefits from the growing adoption of preventive care solutions, such as vaccines and nutritional supplements, to ensure the well-being of horses.

Market Growth Drivers:

The global equine veterinary therapeutics market is propelled by several key factors, including the increasing prevalence of equine diseases such as colic, laminitis, and equine influenza. Rising participation in equestrian sports and recreational activities has elevated the focus on horse health, leading to higher spending on veterinary care. Moreover, advancements in biotechnology have resulted in the development of targeted therapies, enhancing treatment efficacy and minimizing side effects. Another critical driver is the growing awareness among horse owners about the importance of preventive healthcare, which has boosted the demand for vaccines and nutritional supplements. The expanding network of equine clinics and the rising availability of advanced diagnostic tools further support market growth.

Market Restraints:

Despite promising growth prospects, the equine veterinary therapeutics market faces challenges related to high treatment costs, limited availability of specialized veterinarians, and regulatory hurdles. The cost of equine pharmaceuticals and vaccines can be prohibitive for small-scale horse owners, particularly in emerging economies with limited disposable income. Additionally, stringent regulations governing the approval and use of veterinary drugs create compliance burdens for manufacturers and delay product launches. The risk of adverse effects associated with certain therapies and the lack of adequate insurance coverage for equine healthcare further restrain market growth.

Market Opportunities:

The equine veterinary therapeutics market presents significant growth opportunities driven by technological innovations, increasing urbanization, and evolving equine care standards. The integration of digital health technologies, such as wearable monitoring devices for horses, enhances early disease detection and promotes preventive care. Furthermore, the development of novel biologics and gene-based therapies opens new avenues for the treatment of previously untreatable conditions. The rising popularity of equestrian tourism and the growing focus on companion animal health create additional opportunities for market players. Strategic investments in research and development, coupled with collaborations between pharmaceutical companies and equestrian organizations, are expected to drive market expansion.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the equine veterinary therapeutics market globally?
• Which product segments are experiencing the highest demand, and why?
• How are advancements in veterinary medicine influencing the competitive landscape of the equine therapeutics market?
• Who are the key players in the equine veterinary therapeutics market, and what strategies are they employing to maintain market relevance?
• What are the emerging trends and future prospects in the global equine veterinary therapeutics market?

Competitive Intelligence and Business Strategy:

Leading players in the global equine veterinary therapeutics market, including Zoetis Inc., Merck Animal Health, and Boehringer Ingelheim, focus on innovation, product differentiation, and strategic collaborations to gain a competitive edge. These companies are investing in R&D to develop advanced therapies, including long-acting injectable drugs, biologics, and targeted treatments for chronic conditions like arthritis and laminitis. Partnerships with equine healthcare providers, equestrian associations, and veterinary schools facilitate product adoption and market penetration.

Key Companies Profiled:

• Zoetis Inc.
• Merck Animal Health
• Boehringer Ingelheim
• Elanco Animal Health
• Dechra Pharmaceuticals
• Virbac
• Ceva Sante Animale
• Vetoquinol S.A.

Equine Veterinary Therapeutics Industry Segmentation

By Drugs:

• Anti-Inflammatory
• Anti-Infective
• Parasiticides

By Route of Administration:

• Oral
• Parental
• Topical

By Services:

• Diagnostic Tests and Imaging
• Physical Health Monitoring
• Surgery
• Vaccination

By Distribution Channel:

• Veterinary Hospital
• Veterinary Clinics
• Pharmacies and drug stores
• E-commerce

By Region:

• North America
• Europe
• East Asia
• South Asia & Oceania
• Latin America
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Equine Veterinary Therapeutics Market Snapshot, 2025 - 2032
• 1.2. Market Opportunity Assessment, 2025 - 2032, US$ Bn
• 1.3. Key Market Trends
• 1.4. Future Market Projections
• 1.5. Premium Market Insights
• 1.6. Industry Developments and Key Market Events
• 1.7. PMR Analysis and Recommendations

2. Market Overview

• 2.1. Market Scope and Definition
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Opportunity
  • 2.2.4. Challenges
  • 2.2.5. Key Trends
• 2.3. Drugs Lifecycle Analysis
• 2.4. Equine Veterinary Therapeutics Market: Value Chain
  • 2.4.1. List of Raw Material Supplier
  • 2.4.2. List of Manufacturers
  • 2.4.3. List of Distributors
  • 2.4.4. List of Applications
  • 2.4.5. Profitability Analysis
• 2.5. Porter Five Force's Analysis
• 2.6. Geopolitical Tensions: Market Impact
• 2.7. Macro-Economic Factors
  • 2.7.1. Global Sectorial Outlook
  • 2.7.2. Global GDP Growth Outlook
  • 2.7.3. Global Parent Market Overview
• 2.8. Forecast Factors - Relevance and Impact
• 2.9. Regulatory and Technology Landscape

3. Global Equine Veterinary Therapeutics Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

• 3.1. Key Highlights
  • 3.1.1. Market Volume (Units) Projections
  • 3.1.2. Market Size and Y-o-Y Growth
  • 3.1.3. Absolute $ Opportunity
• 3.2. Market Size (US$ Bn) Analysis and Forecast
  • 3.2.1. Historical Market Size Analysis, 2019 - 2023
  • 3.2.2. Current Market Size Forecast, 2025 - 2032
• 3.3. Global Equine Veterinary Therapeutics Market Outlook: Drugs
  • 3.3.1. Introduction / Key Findings
  • 3.3.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Drugs, 2019 - 2023
  • 3.3.3. Current Market Size (US$ Bn) and Volume (Units) Forecast By Drugs, 2025 - 2032
    • 3.3.3.1. Anti- Inflammatory
    • 3.3.3.2. Anti - Infective
    • 3.3.3.3. Parasiticides
    • 3.3.3.4. Others
• 3.4. Market Attractiveness Analysis: Drugs
• 3.5. Global Equine Veterinary Therapeutics Market Outlook: Route of Administration
  • 3.5.1. Introduction / Key Findings
  • 3.5.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Route of Administration, 2019 - 2023
  • 3.5.3. Current Market Size (US$ Bn) and Volume (Units) Forecast By Route of Administration, 2025 - 2032
    • 3.5.3.1. Oral
    • 3.5.3.2. Parental
    • 3.5.3.3. Topical
• 3.6. Market Attractiveness Analysis: Route of Administration
• 3.7. Global Equine Veterinary Therapeutics Market Outlook: Service
  • 3.7.1. Introduction / Key Findings
  • 3.7.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Service, 2019 - 2023
  • 3.7.3. Current Market Size (US$ Bn) and Volume (Units) Forecast By Service, 2025 - 2032
    • 3.7.3.1. Diagnostic Tests and Imaging
    • 3.7.3.2. Physical Health Monitoring
    • 3.7.3.3. Surgery
    • 3.7.3.4. Vaccination
    • 3.7.3.5. Others
• 3.8. Market Attractiveness Analysis: Service
• 3.9. Global Equine Veterinary Therapeutics Market Outlook: Distribution Channel
  • 3.9.1. Introduction / Key Findings
  • 3.9.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Distribution Channel, 2019 - 2023
  • 3.9.3. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
    • 3.9.3.1. Veterinary Hospital
    • 3.9.3.2. Veterinary Clinics
    • 3.9.3.3. Pharmacies and drug stores
    • 3.9.3.4. E-commerce
    • 3.9.3.5. Other
• 3.10. Market Attractiveness Analysis: Distribution Channel

4. Global Equine Veterinary Therapeutics Market Outlook: Region

• 4.1. Key Highlights
• 4.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Region, 2019 - 2023
• 4.3. Current Market Size (US$ Bn) and Volume (Units) Forecast By Region, 2025 - 2032
  • 4.3.1. North America
  • 4.3.2. Europe
  • 4.3.3. East Asia
  • 4.3.4. South Asia and Oceania
  • 4.3.5. Latin America
  • 4.3.6. Middle East & Africa (MEA)
• 4.4. Market Attractiveness Analysis: Region

5. North America Equine Veterinary Therapeutics Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

• 5.1. Key Highlights
• 5.2. Pricing Analysis
• 5.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019 - 2023
  • 5.3.1. By Country
  • 5.3.2. By Drugs
  • 5.3.3. By Route of Administration
  • 5.3.4. By Service
  • 5.3.5. By Distribution Channel
• 5.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2025 - 2032
  • 5.4.1. U.S.
  • 5.4.2. Canada
• 5.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Drugs, 2025 - 2032
  • 5.5.1. Anti- Inflammatory
  • 5.5.2. Anti - Infective
  • 5.5.3. Parasiticides
  • 5.5.4. Others
• 5.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Route of Administration, 2025 - 2032
  • 5.6.1. Oral
  • 5.6.2. Parental
  • 5.6.3. Topical
• 5.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By Service, 2025 - 2032
  • 5.7.1. Diagnostic Tests and Imaging
  • 5.7.2. Physical Health Monitoring
  • 5.7.3. Surgery
  • 5.7.4. Vaccination
  • 5.7.5. Others
• 5.8. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
  • 5.8.1. Veterinary Hospital
  • 5.8.2. Veterinary Clinics
  • 5.8.3. Pharmacies and drug stores
  • 5.8.4. E-commerce
  • 5.8.5. Other
• 5.9. Market Attractiveness Analysis

6. Europe Equine Veterinary Therapeutics Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

• 6.1. Key Highlights
• 6.2. Pricing Analysis
• 6.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019 - 2023
  • 6.3.1. By Country
  • 6.3.2. By Drugs
  • 6.3.3. By Route of Administration
  • 6.3.4. By Service
  • 6.3.5. By Distribution Channel
• 6.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2025 - 2032
  • 6.4.1. Germany
  • 6.4.2. France
  • 6.4.3. U.K.
  • 6.4.4. Italy
  • 6.4.5. Spain
  • 6.4.6. Russia
  • 6.4.7. Turkiye
  • 6.4.8. Rest of Europe
• 6.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Drugs, 2025 - 2032
  • 6.5.1. Anti- Inflammatory
  • 6.5.2. Anti - Infective
  • 6.5.3. Parasiticides
  • 6.5.4. Others
• 6.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Route of Administration, 2025 - 2032
  • 6.6.1. Oral
  • 6.6.2. Parental
  • 6.6.3. Topical
• 6.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By Service, 2025 - 2032
  • 6.7.1. Diagnostic Tests and Imaging
  • 6.7.2. Physical Health Monitoring
  • 6.7.3. Surgery
  • 6.7.4. Vaccination
  • 6.7.5. Others
• 6.8. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
  • 6.8.1. Veterinary Hospital
  • 6.8.2. Veterinary Clinics
  • 6.8.3. Pharmacies and drug stores
  • 6.8.4. E-commerce
  • 6.8.5. Other
• 6.9. Market Attractiveness Analysis

7. East Asia Equine Veterinary Therapeutics Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

• 7.1. Key Highlights
• 7.2. Pricing Analysis
• 7.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019 - 2023
  • 7.3.1. By Country
  • 7.3.2. By Drugs
  • 7.3.3. By Route of Administration
  • 7.3.4. By Service
  • 7.3.5. By Distribution Channel
• 7.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2025 - 2032
  • 7.4.1. China
  • 7.4.2. Japan
  • 7.4.3. South Korea
• 7.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Drugs, 2025 - 2032
  • 7.5.1. Anti- Inflammatory
  • 7.5.2. Anti - Infective
  • 7.5.3. Parasiticides
  • 7.5.4. Others
• 7.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Route of Administration, 2025 - 2032
  • 7.6.1. Oral
  • 7.6.2. Parental
  • 7.6.3. Topical
• 7.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By Service, 2025 - 2032
  • 7.7.1. Diagnostic Tests and Imaging
  • 7.7.2. Physical Health Monitoring
  • 7.7.3. Surgery
  • 7.7.4. Vaccination
  • 7.7.5. Others
• 7.8. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
  • 7.8.1. Veterinary Hospital
  • 7.8.2. Veterinary Clinics
  • 7.8.3. Pharmacies and drug stores
  • 7.8.4. E-commerce
  • 7.8.5. Other
• 7.9. Market Attractiveness Analysis

8. South Asia & Oceania Equine Veterinary Therapeutics Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

• 8.1. Key Highlights
• 8.2. Pricing Analysis
• 8.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019 - 2023
  • 8.3.1. By Country
  • 8.3.2. By Drugs
  • 8.3.3. By Route of Administration
  • 8.3.4. By Service
  • 8.3.5. By Distribution Channel
• 8.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2025 - 2032
  • 8.4.1. India
  • 8.4.2. Southeast Asia
  • 8.4.3. ANZ
  • 8.4.4. Rest of South Asia & Oceania
• 8.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Drugs, 2025 - 2032
  • 8.5.1. Anti- Inflammatory
  • 8.5.2. Anti - Infective
  • 8.5.3. Parasiticides
  • 8.5.4. Others
• 8.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Route of Administration, 2025 - 2032
  • 8.6.1. Oral
  • 8.6.2. Parental
  • 8.6.3. Topical
• 8.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By Service, 2025 - 2032
  • 8.7.1. Diagnostic Tests and Imaging
  • 8.7.2. Physical Health Monitoring
  • 8.7.3. Surgery
  • 8.7.4. Vaccination
  • 8.7.5. Others
• 8.8. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
  • 8.8.1. Veterinary Hospital
  • 8.8.2. Veterinary Clinics
  • 8.8.3. Pharmacies and drug stores
  • 8.8.4. E-commerce
  • 8.8.5. Other
• 8.9. Market Attractiveness Analysis

9. Latin America Equine Veterinary Therapeutics Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

• 9.1. Key Highlights
• 9.2. Pricing Analysis
• 9.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019 - 2023
  • 9.3.1. By Country
  • 9.3.2. By Drugs
  • 9.3.3. By Route of Administration
  • 9.3.4. By Service
  • 9.3.5. By Distribution Channel
• 9.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2025 - 2032
  • 9.4.1. Brazil
  • 9.4.2. Mexico
  • 9.4.3. Rest of Latin America
• 9.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Drugs, 2025 - 2032
  • 9.5.1. Anti- Inflammatory
  • 9.5.2. Anti - Infective
  • 9.5.3. Parasiticides
  • 9.5.4. Others
• 9.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Route of Administration, 2025 - 2032
  • 9.6.1. Oral
  • 9.6.2. Parental
  • 9.6.3. Topical
• 9.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By Service, 2025 - 2032
  • 9.7.1. Diagnostic Tests and Imaging
  • 9.7.2. Physical Health Monitoring
  • 9.7.3. Surgery
  • 9.7.4. Vaccination
  • 9.7.5. Others
• 9.8. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
  • 9.8.1. Veterinary Hospital
  • 9.8.2. Veterinary Clinics
  • 9.8.3. Pharmacies and drug stores
  • 9.8.4. E-commerce
  • 9.8.5. Other
• 9.9. Market Attractiveness Analysis

10. Middle East & Africa Equine Veterinary Therapeutics Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

• 10.1. Key Highlights
• 10.2. Pricing Analysis
• 10.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019 - 2023
  • 10.3.1. By Country
  • 10.3.2. By Drugs
  • 10.3.3. By Route of Administration
  • 10.3.4. By Service
  • 10.3.5. By Distribution Channel
• 10.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2025 - 2032
  • 10.4.1. GCC
  • 10.4.2. Egypt
  • 10.4.3. South Africa
  • 10.4.4. Northern Africa
  • 10.4.5. Rest of Middle East & Africa
• 10.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Drugs, 2025 - 2032
  • 10.5.1. Anti- Inflammatory
  • 10.5.2. Anti - Infective
  • 10.5.3. Parasiticides
  • 10.5.4. Others
• 10.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Route of Administration, 2025 - 2032
  • 10.6.1. Oral
  • 10.6.2. Parental
  • 10.6.3. Topical
• 10.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By Service, 2025 - 2032
  • 10.7.1. Diagnostic Tests and Imaging
  • 10.7.2. Physical Health Monitoring
  • 10.7.3. Surgery
  • 10.7.4. Vaccination
  • 10.7.5. Others
• 10.8. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
  • 10.8.1. Veterinary Hospital
  • 10.8.2. Veterinary Clinics
  • 10.8.3. Pharmacies and drug stores
  • 10.8.4. E-commerce
  • 10.8.5. Other
• 10.9. Market Attractiveness Analysis

11. Competition Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. Market Structure
  • 11.2.1. Competition Intensity Mapping By Market
  • 11.2.2. Competition Dashboard
  • 11.2.3. Apparent Product Capacity
• 11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  • 11.3.1. Merck Animal Heath
    • 11.3.1.1. Overview
    • 11.3.1.2. Segments and Product
    • 11.3.1.3. Key Financials
    • 11.3.1.4. Market Developments
    • 11.3.1.5. Market Strategy
  • 11.3.2. Affymetrix
    • 11.3.2.1. Overview
    • 11.3.2.2. Segments and Product
    • 11.3.2.3. Key Financials
    • 11.3.2.4. Market Developments
    • 11.3.2.5. Market Strategy
  • 11.3.3. Elanco Animal Health
    • 11.3.3.1. Overview
    • 11.3.3.2. Segments and Product
    • 11.3.3.3. Key Financials
    • 11.3.3.4. Market Developments
    • 11.3.3.5. Market Strategy
  • 11.3.4. Zoetis (Pfizer Animal Health)
    • 11.3.4.1. Overview
    • 11.3.4.2. Segments and Product
    • 11.3.4.3. Key Financials
    • 11.3.4.4. Market Developments
    • 11.3.4.5. Market Strategy
  • 11.3.5. Equine Health UK
    • 11.3.5.1. Overview
    • 11.3.5.2. Segments and Product
    • 11.3.5.3. Key Financials
    • 11.3.5.4. Market Developments
    • 11.3.5.5. Market Strategy

12. Appendix

• 12.1. Research Methodology
• 12.2. Research Assumptions
• 12.3. Acronyms and Abbreviations